Alemtuzumab-Ofatumumab in Previously Untreated Symptomatic Chronic Lymphocytic Leukemia
Northwestern University
Northwestern University
M.D. Anderson Cancer Center
University of Pittsburgh
Columbia University
University of Birmingham
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Goethe University
Shanghai Zhangjiang Biotechnology Limited Company
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Arbeitsgemeinschaft medikamentoese Tumortherapie
German CLL Study Group
Weill Medical College of Cornell University
Northwestern University
M.D. Anderson Cancer Center
University of California, San Diego
Mayo Clinic
St. Jude Children's Research Hospital
Mayo Clinic
Fred Hutchinson Cancer Center
Baylor College of Medicine
Baylor College of Medicine
Alliance for Clinical Trials in Oncology
University of Ulm
University of Arizona
M.D. Anderson Cancer Center
Columbia University
National Institutes of Health Clinical Center (CC)
University of Chicago
M.D. Anderson Cancer Center
New York Medical College
German CLL Study Group
Arbeitsgemeinschaft medikamentoese Tumortherapie
University of California, San Francisco
OHSU Knight Cancer Institute
Mayo Clinic
German CLL Study Group
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
University of Arizona
Ohio State University Comprehensive Cancer Center
Yale University
University of Chicago
Baylor College of Medicine
German CLL Study Group
German CLL Study Group
Sanofi